Class 4

Class 4 Medicines Defect Information: Aspen Pharma Trading Limited

Class 4 Medicines Defect Information: Aspen Pharma Trading Limited, Co-trimoxazole 80mg/400mg per 5ml adult suspension, EL (24)A/32

Aspen Pharma Trading Limited has informed the MHRA that an error has been found in the Patient Information Leaflet.

MDR Number: MDR 063-03/24

Company name: Aspen Pharma Trading Limited

Product description: Co-trimoxazole 80mg/400mg per 5ml adult suspension, PL 39699/0038

SNOMED Code: 32280411000001100

Details of the affected batch

Batch NoExpiry DatePack SizeFirst Distributed
B18324E31st May 2028100mlJuly 2024
B99324E31st May 2028100mlJuly 2024
B05924E31st May 2028100mlJuly 2024
B98724E31st May 2028100mlJuly 2024
B95224A31st January 2028100mlApril 2024
B95324A31st January 2028100mlApril 2024
B22823GA31st July 2027100mlSeptember 2023
B85623F30th June 2027100mlJuly 2023
B01923C31st March 2027100mlMay 2023
B55023B28th February 2027100mlMarch 2023
B55323B28th February 2027100mlMarch 2023
B97222L31st December 2026100mlJanuary 2023
B27922I30th September 2026100mlNovember 2022
B60922G31st July 2026100mlAugust 2022
B02122E31st May 2026100mlJune 2022
B71922D30th April 2026100mlMay 2022
B40821K30th November 2025100mlFebruary 2022
B82321F30th June 2025100mlJuly 2021
B77321F30th June 2025100mlJuly 2021
B21921D30th April 2025100mlMay 2021
B96420I30th September 2024100mlNovember 2020
B71220H31st August 2024100mlSeptember 2020

Active Pharmaceutical Ingredient: sulfamethoxazole, trimethoprim

Brief description of problem:

Aspen Pharma Trading Limited has informed the MHRA that an error has been found in the Patient Information Leaflet.

The error is in the section, ‘What co-trimoxazole looks like and contents of the pack’. The PIL states ‘4001mg sulfamethoxazole’ instead of ‘400 mg sulfamethoxazole’. The other sections of the PIL and product information state the correct strength.

Advice to Healthcare Professionals:

Please continue to use the product as normal but be aware of the typographical error highlighted above.

Advice to Patients:

No further action is required by patients. Patients should continue to receive this medicine from these batches as given to you by your healthcare professional. There is no impact to product quality. If you have concerns about a medicine you may be using, please contact your healthcare professional.

Patients who experience adverse reactions or have any questions about the medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.

Company contacts for further information:

For medical information enquiries please contact: Aspenmedinfo@professionalinformation.co.uk,

Tel: 0800 008 7392

To access the full recall: 

Class 4 Medicines Defect Information: Aspen Pharma Trading Limited, Co-trimoxazole 80mg/400mg per 5ml adult suspension, EL(24)A/32